Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03795298
What this trial is testing

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

Who this might be right for
Atrial Fibrillation
Boston Scientific Corporation 1,600
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Not applicableNot Yet RecruitingNCT07747948
What this trial is testing

Population Pharmacokinetics of Apixaban in Asian Patients With Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Chulalongkorn University 200
Not applicableStudy completedNCT04030494
What this trial is testing

Validation Study of an Advanced Blood Pressure Monitor

Who this might be right for
Atrial FibrillationHypertensionValvular Heart Disease
Withings 218
Not applicableStudy completedNCT02674594
What this trial is testing

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

Who this might be right for
Nonvalvular Atrial Fibrillation
Bristol-Myers Squibb 30,000
Testing effectiveness (Phase 2)Study completedNCT00448214
What this trial is testing

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 448
Not applicableStudy completedNCT01800006
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

Who this might be right for
Atrial Fibrillation
Bayer 2,101
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Not applicableStudy completedNCT03362788
What this trial is testing

The Greek AntiPlatElet Atrial Fibrillation Registry.

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Attikon Hospital 654
Not applicableStudy completedNCT03247582
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company 234
Post-approval studies (Phase 4)Study completedNCT02608099
What this trial is testing

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Baim Institute for Clinical Research 300
Not applicableUnknownNCT04062071
What this trial is testing

Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Prince of Wales Hospital, Shatin, Hong Kong 300
Not applicableStudy completedNCT02611635
What this trial is testing

Atrial Fibrillation Patient Preference Study

Who this might be right for
Atrial Fibrillation
Bayer 382
Testing effectiveness (Phase 2)Looking for participantsNCT06279793
What this trial is testing

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

Who this might be right for
Intensive Care UnitCoronary Artery Bypass Grafting (CABG)High Risk Patients+9 more
GCP-Service International West GmbH 550
Not applicableEnrolling By InvitationNCT07339007
What this trial is testing

Observational Study to Validate a Family Physician Echocardiography Training Programme

Who this might be right for
Heart FailureValvular Heart DiseasesAtrial Fibrillation (AF)+2 more
Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC) 500
Not applicableStudy completedNCT03284762
What this trial is testing

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 1,216
Not applicableStudy completedNCT03446794
What this trial is testing

Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis

Who this might be right for
Atrial FibrillationHeart DiseasesRenal Disease+3 more
Fundación EPIC 300
Not applicableStudy completedNCT03488420
What this trial is testing

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

Who this might be right for
Atrial Fibrillation and FlutterValvular Heart Disease
Montreal Heart Institute 136
Testing effectiveness (Phase 2)Study completedNCT01136408
What this trial is testing

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 174
Post-approval studies (Phase 4)UnknownNCT04195997
What this trial is testing

Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

Who this might be right for
Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk
Shanghai Zhongshan Hospital 100
Next Page